Influenza vaccine in patients with asthma

Expert Review of Vaccines

Volumn 5, Issue 1, 2006, Pages 111-118

  Hanania, Nicola A ^a   Atmar, Robert L ^a   Castro, Mario ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; Influenza; Influenza vaccine; Obstructive airway disease; Safety; Vaccination

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; INFLUENZA VACCINE; LIVE VACCINE; PREDNISONE; TRIPLE VACCINE;

ASTHMA; CHRONIC DISEASE; CLINICAL TRIAL; COUGHING; DECUBITUS; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; FEVER; HEALTH CARE COST; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; LUNG CONGESTION; LUNG DISEASE; MALAISE; META ANALYSIS; MORBIDITY; MORTALITY; MYALGIA; PAIN; PNEUMONIA; POPULATION RISK; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; RHINORRHEA; SKIN ALLERGY; SORE THROAT; SWELLING; SYSTEMATIC REVIEW;

ASTHMA; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; RISK FACTORS; VACCINES, INACTIVATED;

EID: 33646477043     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.5.1.111     Document Type: Review

References (90)

1. Barker W. Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States. Am. J. Public Health 76, 761-765 (1986).
2. Sullivan K, Monto A, Longini I. Estimates of the US health impact of influenza. Am. J. Public Health 83, 1712-1716 (1993).
3. Neuzil K, Mellen B, Wright P, Mitchel E, Griffin M. The effect of influenza on hospitalizations, out-patient visits, and courses of antibiotics in children. N. Engl. J. Med. 342, 225-231 (2000).
4. Izurieta HS, Thompson WW, Kramarz P et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N. Engl. J. Med. 342, 232-239 (2000).
5. Thompson W, Shay D, Weintraub E, Brammer L, Anderson L, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289, 179-186 (2003).
6. Thompson WW, Shay D, Weintraub E et al. Influenza-associated hospitalizations in the United States. JAMA 292, 1333-1340, (2004).
7. Mannino DM, Homa DM, Pertowski CA et al. Surveillance for asthma - United States, 1960-1995. MMWR 47, 1-27 (1998).
8. Center for Disease Control. Self-reported asthma prevalence among adults 0150 United States, 2000. MMWR 50, 682-686 (2001).
9. 1 in asthmatic children. Chest. 100, 1235-1238 (1991).
10. Glezen W, Greenberg S, Atmar R, Piedra P, Cough R. Impact of respiratory virus infections on persons with underlying conditions. JAMA 283, 499-505 (2000).
11. Neuzil K, Wright P, Mitchel E, Griffin M. The burden of influenza illness in children with asthma and other chronic medical conditions. J. Pediatr. 137, 856-864 (2000).
12. Couch RB. Prevention and treatment of influenza. N. Engl. J. Med. 343, 1778-1787 (2000). Concise review on influenza prevention, diagnosis and management.
13. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet 362, 1733-1745, (2003).
14. Zimmerman RK, Middleton DB, Smith NJ. Vaccines for persons at high risk due to medical conditions, occupation, environment, or lifestyle, 2003. J. Fam. Pract. 52(Suppl.1), S22-S35 (2003).
15. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 54(RR-8), 1-40 (2005). In-depth review of current recommendations for the prevention and control of influenza published by the US Center for Disease Control and Prevention.
16. National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the Diagnosis and Management of asthma. National Institutes of Health; National Heart, Lung, and Blood Institute, MA, USA. NIH publication #98-4051 (1997).
17. Hak E, Buskens E, van Essen GA et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions. Arch. Intern. Med. 165, 274-280 (2005). Recent review of clinical effectiveness of influenza vaccination in high-risk patients.
18. Centers for disease Control and Prevention. Influenza and pneumococcal vaccination coverage among persons aged ≥65 years and persons aged 18-64 years with diabetes or asthma - United States, 2003. MMWR 53, 1007-1012 (2004).
19. Ford ES, Mannino DM, Williams SG. Asthma and Influenza vaccination. Findings from the 1999-2001 National Health Interview surveys. Chest, 124, 783-789 (2003).
20. Pattemore PK, Johnston SL, Bardin PG. Viruses as precipitants of asthma symptoms. I. Epidemiology. Clin. Exp. Allergy 22, 325-336 (1992).
21. Johnston SL, Pattemore PK, Sanderson G et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 310(6989), 1225-1228 (1995).
22. Atmar RL, Guy E, Guntupalli KK et al. Respiratory tract viral infections in inner-city asthmatic adults. Arch. Intern. Med. 158, 2453-2459 (1998).
23. Johnston SL, Ferrero F, Garcia ML, Dutkowski R. Oral oseltamivir improves pulmonary function and reduces exacerbation frequency for influenza-infected children with asthma. Pediatr. Infect. Dis. J. 24(3), 225-232 (2005).
24. Palache AM. Influenza vaccines. A reappraisal of their use. Drugs 54(6), 841-856 (1997).
25. Palese P, Garcia-Sastre A. Influenza vaccines: present and future. J. Clin. Invest. 110, 9-13 (2002).
26. Keitel WA, Couch RB. Inactivated influenza vaccines. In: Influenza. Potter CW (Ed.), Elsevier Science, London, UK. 145-177 (2002). Comprehensive review of influenza vaccines.
27. Lavanchy D, Osterhaus AD. Recommendations for the use of inactivated influenza vaccines and other preventive measures. Vaccine 19(15-16), 1849-1853 (2001).
28. Demicheli V, Rivetti D, Decks JJ, Jefferson TO. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst. Rev. 3, CD001269 (2004). Recent systematic review on the efficacy of influenza vaccine in adults.
29. Bridges CB, Thompson WW, Meltzer MI et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 284, 1655-1663 (2000).
30. Neuzil KM, DuPont WD, Wright PF, Edwards KM. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr. Infect. Dis, J. 20, 733-740 (2001).
31. Gluck R, Wegmann A. Influenza vaccination in the elderly. Dev. Comp. Immunol. 21(6), 501-507 (1997).
32. Gross PA, Hermogenes AW, Sacks HS et al. The efficacy of influenza vaccine in elderly persons; a meta-analysis and review of the literature. Ann. Intern. Med. 123, 518-527 (1995).
33. Jefferson T, Smith S, Demicheli V, Harnden A, Rivetti A, Di Pietrantonj C. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet 365(9461), 773-780 (2005). Systematic review of the efficacy of influenza vaccine in children.
34. Meltzer MI, Neuzil KM, Griffin MR, Fukuda K. An economic analysis of annual influenza vaccination of children. Vaccine 23, 1004-1014 (2005).
35. Belshe RB, Gruber WC, Mendelman PM et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the Vaccine. J. Peds. 136, 168-175 (2000).
36. Gaglani MJ. Rationale and approach to target children with asthma for annual influenza immunization. Semin. Pediatr. Infect. Dis. 13(2), 97-103 (2002).
37. Neuzil K. Influenza vaccine in children with asthma: Why no progress? J. Pediatr. 138, 301-303 (2001).
38. Rothbarth PH, Kempen BM, Sprenger MJ. Sense and nosense of influenza vaccination in asthma and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 151, 1682-1685 (1995).
39. Cates CJ, Jefferson TO, Bara AI, Rowe BH. Vaccines for preventing influenza in people with asthma. Cochrane Database Sys. Rev. 2, CD000364 (2004). Systematic review of the safety and efficacy of influenza vaccine in patients with asthma.
40. Kramarz P, DeStefano F, Gargiullo PM et al. and the vaccine safety datalink team. Does influenza vaccination prevent asthma exacerbations in children? J. Ped. 138, 306-310 (2001).
41. Christy C, Algine CA, Auinger P, Pulcino T, Weitzman M. Effectiveness of influenza vaccine for the prevention of asthma exacerbations. Arch. Dis. Child 89, 734-735 (2004).
42. Smits AJ, Hak E, Stalman WAB, van Essen GA, Hoes AW, Verheij TJM. Clinical effectiveness of conventional influenza vaccination in asthmatic children. Epidemiol. Infect. 128, 205-211 (2002).
43. Abadoglu O, Mungan D, Pasaoglu G, Celik G, Misirligil Z. Influenza vaccination in patients with asthma: effect on the frequency of upper respiratory tract infections and exacerbations. J. Asthma. 41, 279-283 (2004).
44. Hak E, Hoes AW, Grobbee DE et al. Conventional influenza vaccination is not associated with complications in working-age patients with asthma or chronic obstructive pulmonary disease. Am. J. Epidemiol. 157, 692-700 (2003).
45. Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and out-patient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann. Intern. Med. 130, 397-403 (1999).
46. Bueving HJ, Bernsen RM, de Jongste JC et al. Influenza vaccination in children with asthma: randomized double-blind placebo-controlled trial. Am. J. Respir. Crit. Care Med. 169, 488-493 (2004).
47. Bueving HJ, van der Wouden JC, Raat H et al. Influenza vaccination in asthmatic children: effects on quality of life and symptoms. Eur. Respir. J. 24(6), 925-931 (2004).
48. Hanania NA, Sockrider M, Castro M et al. Immune response to influenza vaccination in children and adults with asthma: Effect of corticosteroid therapy. J. Allergy Clin. Immunol. 113, 711-724 (2004). Demonstrates a potential effect of high dose inhaled corticosteroids therapy on the immune response to inactivated influenza vaccine.
49. Park CL, Frank AL, Sullivan M, Jindal P, Baxter BD. Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy. Pediatrics 98(2 Pt 1), 196-200 (1996).
50. Fairchok M, Trementozzi D, Carter P, Regnery H, Carter E. Effect of prednisone on response to influenza virus in asthmatic children. Arch. Pediatr. Adolesc. Med. 152, 1191-1195 (1998).
51. th Ed. Pickering LK (Ed.). American Academy of Pediatrics, IL, USA. 382-391 (2003).
52. Goldstein LG. Safety and efficacy of influenza vaccine in children. Ann. Pharmacother. 37(11), 1712-1715 (2003).
53. France EK, Glanz JM, Xu S et al. Safety of the trivalent inactivated influenza vaccine among children: a population-based study. Arch. Pediatr. Adolesc. Med. 158(11), 1031-1036 (2004).
54. Zangwill KM, Belshe RB. Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination. Pediatr. Infect. Dis. J. 23(3), 189-197 (2004).
55. Margolis KL, Nichol KL, Poland GA, Pluhar RE. Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial. JAMA 264, 1139-1141 (1990).
56. Govaert TM, Dinant GJ, Aretz K, Masurel N, Sprenger MJ, Knotterus JA. Adverse reactions to influenza vaccine in elderly people: randomized double-blind placebo-controlled trial. BMJ. 307, 988-990 (1993).
57. Allsup SJ, Gosney M, Regan M, Haycox A, Fear S, Johnstone FCW. Side effects of influenza vaccination in healthy older people: a randomized single-blind placebo-controlled trial. Gerontology 47, 311-314 (2001).
58. Kawai N, Ikematsu H, Iwaki N et al. A prospective, internet-based study of the effectiveness and safety of influenza vaccination in the 2001-2002 influenza season. Vaccine 21, 4507-4513 (2003).
59. Nichol KL, Margolis KL, Lind AMS et al. Side effects associated with influenza vaccination in healthy working adults: a randomized, placebo-controlled trial. Arch. Intern. Med. 156, 1546-1550 (1996).
60. Skowronski DM, Strauss B, De Serres G et al. Oculo-respiratory syndrome: a new influenza vaccine-associated adverse event? Clin. Infect. Dis. 36(6), 705-713 (2003).
61. Scheifele DW, Duval B, Russell ML et al. Ocular and respiratory symptoms attributable to inactivated split influenza vaccine: Evidence from a controlled trial involving adults. Clin. Infect. Dis. 36, 850-857 (2003).
62. Piedra PA, Yan L, Kotloff K et al. Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged. Pediatrics 110(4), 662-672 (2002).
63. Piedra PA. Safety of the trivalent, cold-adapted influenza vaccine (CAIV-T) in children. Semin. Pediatr. Infect. Dis. 13(2), 90-96 (2002).
64. Belshe RB, Mendelman PM. Safety and efficacy of live attenuated, cold-adapted, influenza vaccine-trivalent. Immunol. Allergy Clin. North Am. 23, 745-767 (2003).
65. Bergen R, Black S, Shinefield H et al. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatr. Infect. Dis. J. 23(2) 138-144 (2004). Large study evaluating the safety of live attenuated influenza vaccine in children.
66. Glezen WP, Piedra PA, Longine IM, Halloran ME. Safety of cold-adapted live influenza vaccine. Pediatr. Infect. Dis. J. 23(6), 593-594 (2004).
67. Kramarz P, DeStefano F, Gargiullo PM et al. Influenza vaccination in children with asthma in health maintenance organizations. Vaccine Safety Datalink Team. Vaccine 18, 2288-2294 (2000).
68. Kramarz P, DeStefano F, Gargiullo PM et al. Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Vaccine Safety Datalink Team. Arch. Fam. Med. 9(7), 617-623 (2000).
69. Castro M, Dozor A, Fish J et al; American Lung Association Clinical Research Centers. The safety of inactivated influenza vaccine in adults and children with asthma. N. Engl. J. Med. 345, 1529-1536 (2001) Large multicenter study demonstrating the safety of influenza vaccination in adults and children with asthma.
70. Innes A, Beresford E, Bedford J. Influenza vaccination in asthma: a primary care experience. Br. J. Gen. Pract. 50(450), 27-30, (2000).
71. Bell T, Chai H, Berlow B, Daniels G. Immunization with killed influenza virus in children with chronic asthma. Chest. 73, 140-145 (1978).
72. Tata LJ, West J, Harrison T, Farrington P, Smith C, Hubbard R. Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease? Thorax. 58(10), 835-839 (2003).
73. Park CL, Frank A. Does influenza vaccination exacerbate asthma? Drug Saf. 19(2), 83-88 (1998).
74. Ghirga G, Ghirga P, Rodino P, Presti A. Safety of the subunit influenza vaccine in asthmatic children. Vaccine 9(12), 913-914, (1991).
75. Campbell BG, Edwards RL. Safety of influenza vaccination in adults with asthma. Med. J. Aust. 140(13), 773-775 (1984).
76. Bierman CW, Shapiro GG, Pierson WE, Taylor JW, Foy HM, Fox JP. Safety of influenza vaccination in allergic children. J. Infect. Dis. 136 (Suppl.) S652-S655 (1977).
77. Nicholson KG, Nguyen-Van-Tam JS, Ahmed AH et al. Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma. Lancet 351(9099), 326-331 (1998). Evaluates the effect of influenza vaccination on pulmonary function indices in patients with asthma.
78. Watson JM, Cordier JF, Nicholson KG. Does influenza immunization cause exacerbations of chronic airflow obstruction or asthma? Thorax. 52, 190-194 (1997).
79. Bueving HJ, Bernsen RM, de Jongste JC et al. Does influenza vaccination exacerbate asthma in children? Vaccine 23, 91-96 (2004).
80. Reid DW, Bromly CL, Stenton SC, Hendricks DJ, Bourke SJ. A double-blind placebo-controlled study of the effect of influenza vaccination on airway hyperresponsiveness in asthma. Respir. Med. 92, 1010-1011 (1998).
81. Stenius-Aarniala B, Huttunen JK, Pyhala R et al. Lack of clinical exacerbations in adults with chronic asthma after immunization with killed influenza virus. Chest. 89, 786-789 (1986).
82. Kava T, Laitinen LA. Effects of killed and live attenuated influenza vaccine on symptoms and specific airway conductance in asthmatics and health subjects. Allergy 40, 42-47 (1985).
83. Albazzaz MK, Harvey JE, Grilli EA, Caul EO, Roome AP. Subunit influenza vaccination in adults with asthma: effect on clinical state, airway reactivity, and antibody response. Br. Med. J. 294(6581), 1196-1197 (1987).
84. Sener M, Gursel G, Turktas H. Effects of inactivated influenza virus vaccination on bronchial reactivity, symptom scores and peak expiratory flow variability in patients with asthma. J. Asthma. 36, 165-169 (1999).
85. Kava T. Acute respiratory infection, influenza vaccination and airway reactivity in asthma. Eur. J. Respir. Dis. Suppl. 150, 1-38 (1987).
86. Ahmed AH, Nicholson KG, Hammersley VS, Kent J. Influenza vaccination in patients with asthma: effect on peak expiratory flow, asthma symptoms and use of medication. Vaccine 15, 1008-1009 (1997).
87. Chiu WJ, Huo ML, Chen LC et al. Evaluation of clinical and immunological effects of inactivated influenza vaccine in children with asthma. Pediatr. Allergy Immunol. 14, 429-436 (2003).
88. Miller RL, Cheng M, DiMango EA, Geromanos K, Rothman PB; American Lung Association Asthma Clinical Research Centers. T-cell responses and hypersensitivity to influenza and egg antigens among adults with asthma immunized with the influenza Vaccine. J. Allergy Clin. Immunol. 112(3), 606-608 (2003).
89. Atmar RL, Blook K, Keitel W, Couch RB, Greenberg SB. Effect of live attenuated, cold recombinant (CR) influenza virus vaccines in healthy and asthmatic adults. Vaccine 8, 217-224 (1990).
90. Redding G, Walker RE, Hessel C et al. Safety and tolerability of cold-adapted influenza virus vaccine in children and adolescents with asthma. Pediatr. Inject. Dis. J. 21(1), 44-48 (2002). Evaluates the safety of influenza vaccine in children with asthma.